4-Year-Old with Down Syndrome and OSA Benefits from Hypoglossal Nerve Stimulation: Case Study
The patient experienced a 40% decrease in the apnea-hypopnea index after receiving Inspire, currently approved for children with Down syndrome and OSA over age 13.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
